Laurus Labs gets approval from USFDA for Metformin Hydrochloride Tablets

30 Aug 2018 Evaluate

Laurus Labs has received an approval from United States Food and Drug Administration (USFDA) for Metformin Hydrochloride Tablets USP 500mg, 850mg and 1,000mg which are used for treatment of diabetes.

Metformin Hydrochloride Tablets USP 500mg, 850mg, and 1000mg are therapeutically equivalent to Glucophage Tablets 500mg, 850mg, and 1000 mg of Bristol-Myers Squibb Company. The Product and API will be commercialized from Company's Unit 2 located at APSEZ, Atchutapuram, Visakhapatnam, in the state of Andhra Pradesh.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

586.80 5.35 (0.92%)
18-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1748.60
Dr. Reddys Lab 1164.70
Cipla 1508.70
Lupin 2035.30
Zydus Lifesciences 903.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...